Feedback / Questions
clobetasol nanosuspension (APP13007) - Formosa Labs, AimMax Therap
https://www.medthority.com/news/2024/3/fda-approves-app-13007-clobetasol-propionate-ophthalmic-suspension-0.05-for-post-operative-inflammation-and-pain-following-ocular-surgery.--eyenovia-/
Mar 5, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next